RJH Biosciences

Novel transfection reagents

RJH Biosciences develops novel transfection reagents and delivery systems that transport different types of nucleic acids to a range of human cells and cell lines. We develop value-added products in two commercial segments, as transfection reagents for biomedical R&D enterprise and as nucleic acid delivery vehicles for preclinical and clinical applications. We design and develop unique, high quality materials for effective delivery of nucleic acids to meet the emerging needs in biomedical enterprises. We are dedicated to understanding the performance of our products and improving our products such that they meet the needs of our customers. We empower our product users to go further, to see beyond and overcome impediments that have not been possible before. We recognize the continually evolving advancements in nucleic acid science and technology and tailor our products to meet the demands of the new technologies.

Product Range:
- All-Fect siRNA pDNA transfection reagent
- Prime-Fect for transfection of primary cells with plasmid DNA
- Leu-Fect A & B for transfection of suspension growing cells
- Trans-Booster to enhance the transfection efficiency of plasmid DNA
- In Vivo DNA-Fect for delivery of plasmid DNA in animal models
- In Vivo RNA-Fect for delivery of siRNA in mice tumor models
- mRNA-Fect for mRNA delivery
- CRISP-Fect for CRISPR-Cas9 RNP delivery

https://www.rjhbiosciences.com/

Show Product